High-grade serous carcinomas only rarely show high-level amplification of the HER2 gene or overexpression of HER2 protein on the cytoplasmic membrane of tumor cells [30], and these studies are not informative about efficacy of this therapeutic option in mucinous carcinoma. Here, ERBB2 is linked to serous adenocarcinoma.